-
effectivehealthcare-admin.ahrq.gov/health-topics/diabetes-type-2?page=0
May 08, 2018 - symptoms can include
Being very thirsty
Urinating often
Feeling very hungry or tired
Losing weight … Effectiveness Review
Systematic Review Archived March 25, 2013
Strategies To Prevent Weight
-
effectivehealthcare-admin.ahrq.gov/products/glycemic-control/abstract
December 01, 2019 - with basal insulin), are of particular interest as these medications are associated with harms such as weight … Outcomes to be measured include weight gain, hypoglycemic episodes, cardiovascular endpoints, onset of
-
effectivehealthcare-admin.ahrq.gov/products/health-data-mapping/report
June 01, 2021 - consistent evidence of a lack of effect of PGHD interventions on the surrogate outcome of body mass index/weight … For obesity, we rated the health outcomes as unclear, and the surrogate outcomes (body mass index/weight … Student volunteers involved in device usability testing of the Weight Watchers Online app found it well-designed
-
effectivehealthcare-admin.ahrq.gov/products/recombinant-factor-viia/clinician
March 01, 2020 - effect of treating spontaneous intracranial hemorrhage with rFVIIa at doses ≤40 μg/kg of patient body weight … Increased risk for arterial thromboembolic events , particularly at doses >40 μg/kg of patient body weight … effect of treating spontaneous intracranial hemorrhage with rFVIIa at doses ≤40 μg/kg of patient body weight
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/obesity-research-methods_research-protocol.pdf
February 08, 2017 - outcome used in the meta-
analysis.17
As demonstrated in the review,16 few studies included BMI or weight … To address the limitations of the evidence base, this review will include both BMI and weight
outcomes … , as well as the more proximal, weight related behavioral outcomes. … Body weight
ii. BMI
iii. Individual dietary behavior
iv. Individual physical activity behavior
v. … outcomes: Weight and BMI; obesity-related
dietary or physical activity behavioral outcomes).
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/omega-3-maternity_research-protocol.pdf
May 18, 2015 - for preterm birth,
intrauterine growth retardation (IUGR) (small-for-gestational age and low birth weight … );
birth weight, length, and head circumference; neurological development; visual function
in the first … Question (KQ) 1(Maternal exposures and outcomes)
§ Healthy pregnant women (for outcomes of birth weight … • Mean birth weight
• Incidence of low birth weight/small for gestational age
o Pediatric Outcomes … OR weight))
OR newborn OR neonatal OR (grow* AND (child* OR infant* OR infancy)) OR "Retinopathy of
-
effectivehealthcare-admin.ahrq.gov/products/effect-dietary-digestible/research
March 01, 2025 - The evidence was insufficient to determine an association between carbohydrate intake and weight or body … conducted, one addressing cardiovascular outcomes and the second addressing incidence of T2D, body weight … The evidence was insufficient to determine an association between carbohydrate intake and weight or body
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_disposition-comments.pdf
August 12, 2016 - As the reviewer notes, we
excluded weight loss
studies. … We would have captured
weight changes subgroup
analyses, if reported. … change since weight change could relate to many of
the outcomes being examined. … Weight change was not an
outcome of interest. Weight
loss intervention studies
were excluded. … Weight
change was not reported in
eligible studies that we saw.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
February 01, 2008 - pharmacologic agent within the defined classes (oral antiplatelet agents, injectable
low molecular weight … Classes include oral antiplatelet
agents, injectable low molecular weight heparins (LMWH), injectable … heparin versus low-molecular weight heparin plus compression stockings versus
compression stockings … UFH.mp
46. heparin, low-molecular weight/
47. low molecular weight heparin.mp
48. … UFH.mp
28. heparin, low-molecular weight/
29. low molecular weight heparin.mp
30.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
February 01, 2008 - pharmacologic agent within the defined classes (oral antiplatelet agents, injectable
low molecular weight … Classes include oral antiplatelet
agents, injectable low molecular weight heparins (LMWH), injectable … heparin versus low-molecular weight heparin plus compression stockings versus
compression stockings … UFH.mp
46. heparin, low-molecular weight/
47. low molecular weight heparin.mp
48. … UFH.mp
28. heparin, low-molecular weight/
29. low molecular weight heparin.mp
30.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
January 01, 2015 - This is particularly the case with the weight key
points (p20-1). … Weight effect summary: TZD and SU
associated with weight gain, DPP4 inhibitors with
weight maintenance … , and GLP1 agonists and SGLT2
inhibitors with weight loss. … insulin with weight
gain? … We have added that insulin is
associated with weight gain.
-
effectivehealthcare-admin.ahrq.gov/products/diabetes-glucose-control/research
January 01, 2020 - non-inferiority relative to insulin glargine 10 and insulin aspart. 11 These trials also demonstrated weight … of individuals with obesity was highest in the group prescribed exenatide, an anticipated finding as weight … The known side-effect of weight loss could have motivated use of this medication, although we cannot … Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated … Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label_executive.pdf
January 01, 2007 - Olanzapine caused significant weight gain in all
studies. … In two pooled
RCTs of dementia patients, olanzapine users were
6.12 times more likely to report weight … gain of 1.0,
0.7, and 0.4 pounds while on treatment, compared
to a weight loss among placebo-treated … Even greater weight gain
relative to placebo has been reported in trials of
non-elderly adults. … Mean weight
gain in the risperidone groups ranged from 2.1 kg
to 3.9 kg per study.
-
effectivehealthcare-admin.ahrq.gov/health-topics/diabetes-type-2?page=1
July 10, 2012 - symptoms can include
Being very thirsty
Urinating often
Feeling very hungry or tired
Losing weight … Research Protocol Archived October 25, 2011
Comparative Effectiveness of Approaches to Weight
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
January 01, 2010 - maintain normoglycemia without inducing
significant hypoglycemia, and to maintain normal/ideal body weight … risk for severer hypoglycemic episodes.
10
Finally, intensive insulin
therapy can also lead to weight … There was a statistically significant increase in mean birth weight associated with CSII when
compared … Weight gain
d. Hypoglycemia frequency
3. Clinical outcomes
a. … Weight gain associated with intensive therapy in the diabetes control and
complications trial.
-
effectivehealthcare-admin.ahrq.gov/system/files/docs/topic-brief-antenatal-care.pdf
April 01, 2021 - stress and
anxiety
Fetal/neonatal outcomes:
Mortality; morbidity (e.g. pre-term birth, low
birth weight … stress and
anxiety
Fetal/neonatal outcomes:
Mortality; morbidity (e.g. pre-term birth, low
birth weight … various approaches to telehealth-delivered antenatal
care, including remote patient monitoring of weight … Effect of Lifestyle Coaching Including Telemonitoring
and Telecoaching on Gestational Weight Gain and … Postnatal Weight Loss: A Systematic Review.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
March 01, 2019 - Seizures
• Serious adverse events
• Suicide/suicide attempt
• Suicidal thoughts
• SIADH/hyponatremia
• Weight … cognitive function, falls,
fracture, mortality, seizures, serious AEs, hyponatremia, suicide/
attempt, weight … fractures, mortality, serious
ADEAE, seizures, sodium/hyponatremia, suicidal thoughts, suicide/
attempt, weight … SSRI 2 RCTs10,20 Any AE, blood pressure, falls, fractures, mortality, serious AE, weight, withdrawal … SSRI 1 RCT22 Any AE, blood pressure, hospitalization, serious AE, weight, withdrawal due to AE
Trazodone
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/ijzerman_ahrq-webinar-mcda.pdf
January 01, 2011 - Dia 1
1
Integrating stakeholder preferences in
comparative effectiveness research
using multi-criteria decision analysis
(MCDA) and Conjoint Analysis (CA)
Maarten J. IJzerman, PhD
Professor and chair, department Health Technology &
Services Research
m.j.ijzerman@utwente.nl
Multiple endpoints in …
-
effectivehealthcare-admin.ahrq.gov/products/type-2-diabetes-medications-update/research-protocol
December 01, 2019 - morbidity and mortality. 1-3 Management of type 2 diabetes is complex and involves recommendations for weight … 2 for lists of comparisons) for the intermediate outcomes of glycemic control (in terms of HgbA1c), weight … Intermediate outcomes are glycemic control, serum lipid levels, weight, and blood pressure. … Intermediate outcomes are glycemic control, serum lipid levels, weight, and blood pressure. … For Key Question 1, we included the following outcomes: HgbA1c, weight, and serum lipid levels (HDL,
-
effectivehealthcare-admin.ahrq.gov/products/meditation/research-protocol
December 01, 2019 - of meditative programs on affect, attention, health-related behaviors affected by stress, pain, and weight … and negative affect, attention, well-being, health-related behaviors affected by stress, pain, and weight … Question 4:
What are the efficacy and harms of meditation programs on pain and weight among those with … However, since weight is affected by multiple inputs including eating, weight will be evaluated as its … (body mass index and weight loss)
Harms (any noted by the study such as exacerbation of psychosis